MAPT and Alzheimer disease: To mimic the progression of tau pathology in AD, where tau pathology spreads from the EC to the hippocampus, we performed unilateral microinjections of recombinant tau fibrils into the left medial entorhinal cortex of 2.5-month-old P301S human tau transgenic mice (PS19) (Figure 1A).